Skip to main content
. 2021 Dec 2;11:23280. doi: 10.1038/s41598-021-02695-0

Figure 2.

Figure 2

Screening heterogenous cell lines leads to only few potential targets. (A) Heatmap showing the alterations of representation of 27,500 shRNAs in HL-60, Kasumi-1 and MV4-11 exposed to sublethal concentrations of azacytidine (AZA) at day 5. (B) Heatmap showing the alterations of representation of 27,500 shRNAs in HL-60, Kasumi-1, MV4-11 and primary human blasts exposed to sublethal concentrations of cytarabine (AraC) at day 5. (C) Heatmap depicting changes in representation of 27,500 shRNAs over the course of 5 days in HL-60, Kasumi-1 and MV4-11.